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Abstract 
Twenty newly diagnosed breast cancer patients were assessed for serum vitamin A, β - carotene 
and total cholesterol levels with their matched control (n = 20). The mean age and standard 
deviation of pre-menopausal breast cancer patients was 34.75± 6.57 while the mean age and 
standard deviation for controls was 32.00 ±8.79 years. There was no statistical difference in age 
between the two groups (P< 0.05). There was evidence of decrease in the mean serum vitamin A 
with increasing stage of advanced breast cancer. However, the mean serum β−carotene level 
showed significant decrease in trend with increasing stage of advanced breast cancer (P< 0.05). 
Serum total cholesterol was negatively correlated with serum vitamin A but was found to be 
positively correlated though non-significantly with serum β−carotene in breast cancer patients 
and control (r = 0.10, p> 0.95 for cases; r = 0.05, p> 0.05 for control). 
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Plants, fungi and bacteria synthesize 
carotenoids de novo while animals do not and 
rather obtain carotenoids from the diet and are 
enzymatically altered to vitamin A (Miki, 1991). 
Carotenoids perform a variety of biological 
functions which include functioning as vitamin 
A precursors (Matsuno, 1991), scavenger and 
quencher against free radicals and active singlet 
oxygen (Miki, 1991), anti-cancer agents 
(Krinsky, 1989) and immune system enhancers. 
Actions of carotenoids are either physiological 
or pharmacological (Olson, 1989) and may be 
related to intact carotenoid molecule rather than 
to a specific metabolite. 
The inverse relationship between the 
ingestion of carotenoid – containing fruits and 
vegetables with the risk of certain forms of 
cancer has attracted significant attention. 
The inverse relationship of blood 
β−carotene level with breast cancer has hitherto 
been restricted only to post-menopausal cases 
(Potischman et al; 1990). Pre-menopausal breast 
cancer patients has significantly lower blood 
retinol and β−carotene levels compared to post-
menopausal breast cancer patients (Wald et al; 
1984). 
Reports show that the mean serum 
vitamin A level decrease significantly with 
increasing stage of the disease (Potischman et al; 
1990; Torun et al; 1995). 
Lack of knowledge of the role or 
relationships of cholesterol and breast cancer 
might mean that its association with cancer is 
secondary. However, serum cholesterol has been 
reported to be positively associated with serum 
vitamin A in all cancer sites  (Kark et al; 1982) 
while little correlation was found between blood 
total cholesterol and β−carotene blood levels in 
breast cancer patients (Potischman et al; 1990; 
Stahelin et al; 1991). 
The objectives of this work are therefore 
to:  
i. predict the trend of vitamin A and 
β−carotene in advanced stages of breast 
cancer. 
ii. test the hypotheses of low mean total 
cholesterol blood value in newly diagnosed 
pre-and post-menopausal breast cancer 
Nigerian women. 
iii. deduce the association of serum total 
cholesterol to serum vitamin A and 
β−carotene in newly diagnosed breast 
cancer patients. 
MATERIALS AND METHODS 
Test and individuals were selected from 
weekly checks of patients in the Surgical and 
Radiotherapic Units of University College 
Hospital, Ibadan, Nigeria between November 
1996 to June 1997. Cases consisted of twenty 
newly diagnosed histologically proven breast 
cancer patients (women only) with stages I, II, 
III and IV of the disease. Control subjects 
consisted of twenty patients who had negative 
history of breast cancer and malignant tumour, 
evidence of hepatic, vascular and metabolic 
disorders. 
5mls 12 hours fasting blood samples 
were collected from both test and control 
individuals using sample bottles without 
anticoagulants. Blood was centrifuged at 3000xg 
for 10 mins. The sera were separated and stored 
at – 500C and analysed when necessary for 
various biochemical parameters. 
Serum vitamin A (retinol) and 
β−carotene were assayed spectrophotometrically 
according to the method of Neeld and Pearson 
(1963). 1ml serum was pipetted into a centrifuge 
tube followed by the addition of 1ml of 95% 
ethanolic KOH and 1.5ml of hexane. The 
mixture was stoppered and vortexed vigorously 
for 2mins and centrifuged at 3000xg for 10mins. 
2mls of the upper hexane extract was transferred 
into a dry test tube and the absorbance of the 
extract read at 450nm against hexane blank with 
Corning 258 spectrophotometer. The content of 
the curette was poured into a dry clean test tube. 
The extract was evaporated to dryness in a water 
bath (at 400C). 0.1ml of chloroform was then 
added to the residue in the test tube followed by 
the addition of 0.1ml acetic anhydride. The 
solution was capped to minimize evaporation 
and absorbance of the blue colour developed 
was read at 620nm with Corning 258 
spectrophotometer at exactly 30secs after the 
addition of 1.0ml mixture of trifluoroacetic acid 
– chloroform reagent against blank containing 
0.1ml of choloroform, 0.1ml of acetic anhydride 
and 1.0ml of trifluoroacetic acid – chloroform 
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reagent. The vitamin A concentration was then 
determined from the standard curve. 
Serum total cholesterol was determined 
spectrophotometrically according to the method 
of Zlatkis et al (1953). The assay involved the 
addition of a fixed volume of concentrated 
sulphuric acid, glacial acetic acid and ferric 
chloride solution to 0.1ml serum. The full colour 
development is purple and required 
approximately 1 minute. 0.1ml serum was 
pipetted into 3ml of glacial acetic acid in a test 
tube followed by the addition of 2ml of colour 
reagent. The absorbance of the solution was read 
at 560nm on Corning 258 spectrophotometer. 
The serum total cholesterol was then determined 
from standard curve. 
Student’s t-test was used for statistical 
analysis. t-values < 0.05 were considered 
significant. 
RESULTS  
      It can be observed from the table that pre-
menopausal breast cancer patients had 
significantly lower mean total cholesterol level 
compared to post-menopausal breast cancer 
patients (P< 0.05). In addition, the result 
indicated that both pre-and post-menopausal 
breast cancer patients had lower mean serum 
total cholesterol compared to their matched 
control. 
 
      Table 1: Mean serum cholesterol level (mg/dl) in different stages of breast cancer 
 Pre-menopausal women  
(< 45yrs) 
Post-menopausal women  
(> 45yrs) 
Cases   
Number  
Mean age ± SD (yrs) 
Mean serum cholesterol (mg/dl) 
12 
34.75 ± 6.57 
126.31 ± 23.56 
8 
58.88 ± 7.06 
180.20 ± 41.34 
Number  
Mean age ± SD (yrs) 
Mean serum cholesterol (mg/dl) 
12 
32.00 ± 8.79 
174.56 ± 51.77 
8 
50.75 ± 6.24 
198.60 ± 39.98 
          SD = standard deviation 
 
      Table 2: Mean serum vitamin A and β-carotene levels in advanced stages of breast neoplasm 
Stage of breast 
cancer 
Number 
Mean serum retinol level 
(µg/dl) 













       Table 3: Shows Pearson’s correlation between serum total cholesterol with serum vitamin A and           
        β-carotene in breast cancer. 
 Cases, n = 20 Controls, n = 20 
 Serum  










Serum total cholesterol 
(µg/dl) 
- 0.30  0.10 - 0.14 0.10 
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 The mean serum vitamin A and β-
carotene levels in advanced stages of breast 
malignancy are shown in table 2. 
There was significant decrease in the 
mean serum vitamin A with increasing stage of 
advanced breast cancer (P < 0.05). However, the 
mean serum β-carotene showed significant 
decrease with increasing stage of advanced 
breast cancer. 
From the analysed data, serum total 
cholesterol was negatively correlated with serum 
vitamin A in both test and control individuals 
but was found to be positively correlated though 
non-significantly serum β-carotene in breast 
cancer (r = 0.10 for cases and r = 0.05 for 
controls). 
DISCUSSION 
From the results obtained in this 
investigation, serum total cholesterol was 
negatively correlated with serum vitamin A. 
This observation is different from the report of 
Kark et al (1982) where there was positive 
correlation between serum total cholesterol and 
serum vitamin A in all cancer sites. 
Alternatively, the mean serum β-
carotene level showed significant decrease with 
increasing degree of breast cancer. This 
observation is similar to the reports of earlier 
investigators that gave significant decreases of 
mean blood β-carotene level with increasing 
stages of the disease (Potischman et al, 1990; 
Torun et al; 1995). It is suggested that patients 
with the later stage of breast cancer might have 
altered their intake to a greater degree than 
patients with earlier stage of breast cancer. 
There is an evidence in this study of 
significant decrease in trend in the mean serum 
vitamin A level with increasing stage of 
advanced breast cancer. This lends support to 
the earlier report of Ramaswamy and 
Krishnamorthy (1996). 
Result of this investigation also revealed 
that serum total cholesterol was positively 
correlated though weakly with serum β-carotene 
in breast cancer patients. This is in keeping with 
the evidence of positive correlation between 
blood total cholesterol and β-carotene in patients 
with breast cancer (Potischman et al 1990; 
Stahelin et al, 1991). 
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